As an important component in the drug development process, metabolic profiling provides information regarding the identity and amount of metabolic breakdown products in a variety of different matrices. Southern Research routinely evaluates parent compound and drug metabolite levels in both preclinical and clinical samples. In addition, we offer the capability to conduct interspecies comparisons to assist in preclinical species selection for toxicology studies.
For more information about our capabilities, contact us at:
BusDev@SouthernResearch.org
888-322-1166 (U.S.)
1-205-581-2830 (International)